Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians.

ABSTRACT:

Background

The degree of ADHD-related difficulties - reflecting overall impairment, social functioning, and quality of life - may be perceived differently by adolescent patients, parents and physicians. The primary aim of this study was to investigate ADHD-related difficulties during atomoxetine treatment, as perceived by the three different raters. Secondary objectives focused on effectiveness and tolerability of atomoxetine treatment in a population of adolescent patients with ADHD.

Methods

Adolescents with ADHD, aged 12-17 years, received open-label atomoxetine (0.5-1.2 mg/kg/day) up to 24 weeks. ADHD-related difficulties at various times of the day were rated using the Global Impression of Perceived Difficulties (GIPD) instrument. Inter-rater agreement was analyzed using

SUBMITTER: Dittmann RW 

PROVIDER: S-EPMC2746185 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature